- Global Pharma News & Resources

Facial Injectables Market Foreseen to Exceed US$ 15,459.3 Million by 2027 | CAGR: 14.9%: Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

The global facial injectables market, by product type (Dermal Fillers (Hyaluronic Acid Fillers, Collagen Fillers and Synthetic Fillers) and Anti-wrinkle Injections (Botulinum Toxin A and Poly-L-lactic acid (PLLA)), by application (Wrinkle Reduction, Facelift, Lip Enhancement, and Others), by end user (Hospitals, Beauty Clinics, and Dermatology Centers), and by region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), accounted for US$ 5,088.5 million in 2019, and is now expected to exhibit a robust CAGR of 14.9% over the projected period (2019-2027).

Get FREE Sample PDF Including COVID-19 Impact Analysis:

The renowned players operating in the global facial injectables market have taken up effective strategies, such as collaborations and novel product launches strategies, in order to address the unmet aesthetic needs of individuals, as well as provide physicians (mainly cosmetologists) with new, more enhanced facial injectable products.  For instance, in March 2017, Galderma, a leading company offering medical solutions for skin and health, joined forces with Colorescience, an organic skincare solutions provider, in a bid to expand its skincare portfolio, which includes various conventional facial injectables for cosmetic treatments.

Numerous organizations across the globe have been conducting educational programs and scientific meetings to provide information about the latest research studies and augment awareness among patients and plastic surgeons.  This is a pivotal factor facilitating the global market growth. For instance, the International Society of Aesthetic Plastic Surgery (ISAPS) is a professional organization for board-certified aesthetic plastic surgeons, and is dedicated to promoting excellence in the field of aesthetic plastic surgery. This organization is known for conducting instructional courses, educational programs, and symposia, to inform people about some of the most advanced techniques, such as botulinum toxin and dermal fillers. Moreover, the American Academy of Facial Esthetics (AAFE) provides information about non-surgical and non-invasive facial injectable techniques to healthcare professionals worldwide through courses. The AAFE is also committed to providing the best possible outcomes in areas of facial esthetics and facial pain treatment.

Special Requirements?
We value your investment and offer customization as per your requirements.

Share your precise requirements @

Key Takeaways:

  • The global facial injectables market is poised to grow considerably over the forecast timeframe, owing to the increasing approvals and introduction of novel products.
  • Among product types, the dermal fillers segment is expected to hold major revenue share in 2027. The popularity of dermal fillers is increasing rapidly as they rejuvenate and enhance aesthetic improvement with the advantages of quick, relatively inexpensive, and increasingly longer-lasting results for facial wrinkles and deeper folds.

Leading Players:

The major players operating in the global facial injectables market include Allergan plc, Galderma S.A., Medytox Inc., SciVision Biotech Inc., Croma-Pharma GmbH, Anika Therapeutics, Inc., Merz Pharmaceuticals, Sinclair Pharma plc, Suneva Medical, Inc. and Zimmer MedizinSysteme GmbH.

Browse Press Release:

Key Market Developments:

In March 2017, Allergan Plc. received the U.S. Food and Drug Administration (FDA) approval for its Juvederm Vollure XC, which is indicated for the correction of moderate-to-severe facial wrinkles and folds, such as nasolabial folds in adults aged above 21 years.

In May 2018, Lsf Farma Ltd. launched the Bliss dermal fillers in the U.K. market. The variations of the Bliss dermal filler include Bliss Soft with an 18 mg/ml concentration, Bliss Derm with a 23 mg/ml concentration, and Bliss Ultra with a concentration of 26 mg/ml. These three products are help alter the dermal skin tissues, lift and contour them, and provide immediate and durable results. The product was introduced in India, Europe, and Turkey in November 2017.

Apply Promo Code “STAYHOME” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website –


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 05-Oct-2020